Novo Nordisk A/S · NVO · Next earnings

Novo Nordisk A/S reports Wednesday, Nov 4, 2026

NVO reports before market open with consensus EPS at $0.73 and revenue at $11.07B. Last quarter: Novo Nordisk Q3: obesity demand supports growth, pricing and LOE remain risks

Reports Before market open0 days awayDate estimated Healthcare

What the street expects

Consensus for the coming report
Consensus EPS $0.73 Calendar consensus
Consensus revenue $11.07B Calendar consensus
Report date Nov 4, 2026 Wednesday, date estimated
Session Before market open 0 days away

Where NVO left off: FY2026 Q3

Full report

Novo Nordisk Q3: obesity demand supports growth, pricing and LOE remain risks

EPS surprise — Reported — vs $0.73
Revenue surprise — Reported — vs $11.07B
Stock move +6.4% Event window
Subsequent drift 0.0% Up to 20 sessions

The Q3 analysis says 2026 sales and profit growth guidance was raised to -2% to +2% at constant exchange rates. The prior-quarter analysis lists full-year sales growth guidance of 0% to 6%; these summaries do not reconcile the apparent direction of change, so the delta is unclear.

What to watch on the call

Carried forward from the last transcript

Risks management flagged

  • Price erosion and gross-to-net adjustments could pressure profitability.
  • Loss of exclusivity in Canada and upcoming exposure in China could weigh on revenue.
  • Regulatory uncertainty could affect timing of planned launches.
  • Growth durability may depend on Bridge program support and payer decisions.

Questions analysts left open

  • Whether growth remains sustainable as the Bridge program contribution normalizes.
  • How pricing and gross-to-net adjustments affect profit forecasts.
  • The scale of loss-of-exclusivity impacts in 2027.
  • The assumptions supporting 2027 guidance and Q4 performance.

Ask FN2 about NVO next report

Transcript, numbers and history already loaded
What should I watch for in NVO's next earnings report?How did NVO guide last quarter, and is consensus above or below that?Give me the bull and bear case going into NVO earnings.

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Get the NVO recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Recent NVO quarters

All NVO earnings
+6.4%FY2026 Q3

Sources

  1. FN2 corporate events calendar, resolved from the earnings calendar feed
  2. FN2 earnings calendar analyst consensus
  3. Earnings call transcript analysis, FY2026 Q3

Methodology

The report date comes from FN2's resolved corporate-events calendar and is marked estimated until the company confirms it. Consensus figures are the calendar's latest analyst estimates for the fiscal period and are not an FN2 forecast.

Risks and open questions are carried forward verbatim from FN2's structured analysis of the previous earnings call. Missing values stay missing and are never estimated.

By FN2 Research · Updated . For educational purposes only; not investment advice.